1. Greater Manchester Cancer
Vanguard Innovation
Establishing a Cancer Intelligence Service for Greater Manchester and Eastern Cheshire
Worth noting in the spiel that this includes Cheshire East?
28 February 2017

2. Before we start… There are no planned fire drills
Greater Manchester Cancer
Before we start…
Vanguard Innovation
There are no planned fire drills
Toilets are in the reception area on the right
We will be taking photos – please let us know if you don’t want to be pictured
Mobiles on silent please

3. Our team: Adrian Hackney – Project Lead Jac Livsey – Clinical Lead
Greater Manchester Cancer
Our team:
Vanguard Innovation
Adrian Hackney – Project Lead
Jac Livsey – Clinical Lead
Catherine O’Hara – Principal Analyst
Nadeem Ahmed – Informatics Lead
Darren Griffiths – Associate Director (Finance)
Tracey Wright – Service Delivery Manager
Jon Bruce – Senior Clinical Analyst
Emeka Eze – Senior Clinical Analyst

4. This evening’s panel: Adrian Hackney – Project Lead
Greater Manchester Cancer
This evening’s panel:
Vanguard Innovation
Adrian Hackney – Project Lead
Jac Livsey – Clinical Lead
Frances Cox – I Want Great Care
Catherine O’Hara – Principal Analyst
Nadeem Ahmed – Informatics Lead

5. The national Cancer Vanguard
Greater Manchester Cancer
The national Cancer Vanguard
Vanguard Innovation
Single national Cancer Vanguard – ‘Accountable Clinical Network for Cancer’ – Greater Manchester Cancer Vanguard Innovation, Royal Marsden Partners & UCLH Cancer Collaborative
Implementing ‘Achieving World Class Cancer Outcomes’ – to see radical improvements in cancer outcomes
Aligning with local Sustainability and Transformation Planning (STP) and Cancer Board structures
Population covered is over 10 million (2.8m in GM)
Two-year programme testing new replicable models of cancer care delivery and commissioning – formally commenced in April 2016

6. What are we aiming to do? Provide cancer intelligence for
Greater Manchester Cancer
What are we aiming to do?
Vanguard Innovation
Provide cancer intelligence for
1) Patients and their families to help them make informed decisions
and
2) Stakeholders to ensure the best possible delivery of, and access to, cancer services

7. What should the intelligence service deliver?
Greater Manchester Cancer
Vanguard Innovation
What should the intelligence service deliver?
Easy access to audience targeted information
Locally relevant metrics and intelligence
Population and sub-population specific measures and analyses
Timely access to information
Investigative analysis of trends and outliers
Asking the right questions

8. How are going to deliver intelligence for our region?
Greater Manchester Cancer
Vanguard Innovation
How are going to deliver intelligence for our region?
PHE data sources
Patient reported outcomes
Local data sources

9. What questions are important to ask?
Greater Manchester Cancer
What questions are important to ask?
Vanguard Innovation
intelligence
Clinical outcomes
Provider performance
Patient reported outcomes
Patient experience
% patients who lived at least one year after diagnosis?
% treated within 62 days?
% patients diagnosed at early stage?
Compared to before your care or treatment, how would you rate your quality of life?
How long have you been waiting for this appointment?
Have you felt involved in the decisions made about your care?

10. What have we achieved so far?
Greater Manchester Cancer
What have we achieved so far?
Vanguard Innovation
Asking users about what they want – ongoing
Dashboard design ideas
Access to PHE data to enable locally relevant measures and intelligence
Exploring access to local data sets
iWantGreatCare

11. iWantGreatCare Greater Manchester Cancer
Vanguard Innovation
World’s largest patient review site – over 4 million patient reviews published
Patient experience and outcomes in real time
Reviews of individual clinicians, hospitals, community services, hospices, GP practices etc.
Approx 100,000 new reviews every month
Operating internationally in 23 countries, 18 languages
Question sets developed and refined over 8 years to meet needs of patients and providers
Involved in Cancer Vanguard since Feb 2016

12. iWGC & the Vanguard Greater Manchester Cancer
Vanguard Innovation
Questions applicable to each care setting that are easy to understand and to complete, providing the opportunity for patients and carers to provide feedback on care and treatment across all contact points.
Questions devised to address some of the key indicators and outcomes of the Vanguard, such as:
Respect for patient-centred values (including dignity, quality of life, shared decisions)
Information and communication (on care and treatment and the involvement of family and friends)
Coordination and integration of care across and within services
Access to care, in particular the timeliness of access to services
Demographics to enrich data analysis.   

13. Data collection and benchmarking
Greater Manchester Cancer
Data collection and benchmarking
Vanguard Innovation
New Vanguard question sets developed in consultation with stakeholders for:
Acute setting
Community setting
Palliative Care
Paediatrics
All question sets have questions in common with each other and with the other questions asked by iWGC partners across the UK for cancer and non-cancer care.
Ability to benchmark cancer services:
By provider
By care type
By stage of patient journey
Against general quality of care in the NHS   

14. Real-time data Greater Manchester Cancer
Vanguard Innovation
Reports will be available to staff real-time, and data analysis tools provided to deep dive the feedback:   

15. Greater Manchester Cancer
Vanguard Innovation

16. Greater Manchester Cancer
Vanguard Innovation
Our next Showcase: CANCER PREVENTION 28 March 2017, from 5.15 pm until 6.15 pm The Blackett Theatre, Schuster Building, University of Manchester, Brunswick Street, Manchester M13
Vanguard Innovation
Web: gmcancervanguard.org